Source - SMW
Cantor Fitzgerald today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its price target at 1500p.

Related Charts

Dechra Pharmaceuticals (DPH)

-29.00p (-2.28%)
delayed 18:15PM